DrugId:  1
1. Name:  Lyme disease vaccine (recombinant OspA)
2. Groups:  Approved, Withdrawn
3. Description:  Vaccine against Lyme disease that contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. It is conjugated with alum (aluminum hydroxide) as an adjuvant.
4. Indication:  For prophylactic treatment of Lyme Disease
